Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Claims & Support/References for Claims
  4. Footnotes Print ad full page + 1/3
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Footnotes Print ad full page + 1/3

Scheduled Pinned Locked Moved Claims & Support/References for Claims
3 Posts 2 Posters 481 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • J Offline
    J Offline
    joao.borges
    wrote on last edited by
    #1

    Hi there, this question is related to a HCP printed ad, size full page and 1/3 (full page and column)

    Based on the guidelines is it allowed to place footnotes in the 1/3 (column) portion of the ad? in this case, footnotes include: Indication
    & Study design details

    Thank you for the help!

    Jennifer CarrollJ 1 Reply Last reply
    0
    • J joao.borges

      Hi there, this question is related to a HCP printed ad, size full page and 1/3 (full page and column)

      Based on the guidelines is it allowed to place footnotes in the 1/3 (column) portion of the ad? in this case, footnotes include: Indication
      & Study design details

      Thank you for the help!

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by
      #2

      Hello @joao-borges

      Yes, you are allowed to place the footnotes on the 1/3 portion if presented side-by-side and clearly part of the same ad. If the column exists somewhere else in the journal or looks distinctly separate from the rest of the ad, the footnotes may not be allowed to be relegated to that space. As a courtesy, please note that indications should never appear as a footnote. It should always appear in the body copy (s2.10.1).

      J 1 Reply Last reply
      0
      • Jennifer CarrollJ Jennifer Carroll

        Hello @joao-borges

        Yes, you are allowed to place the footnotes on the 1/3 portion if presented side-by-side and clearly part of the same ad. If the column exists somewhere else in the journal or looks distinctly separate from the rest of the ad, the footnotes may not be allowed to be relegated to that space. As a courtesy, please note that indications should never appear as a footnote. It should always appear in the body copy (s2.10.1).

        J Offline
        J Offline
        joao.borges
        wrote on last edited by
        #3

        @jennifer-carroll thank you Jennifer!

        1 Reply Last reply
        0
        Reply
        • Reply as topic
        Log in to reply
        • Oldest to Newest
        • Newest to Oldest
        • Most Votes


        • Login

        • Don't have an account? Register

        • Login or register to search.
        • First post
          Last post
        0
        • Categories
        • Recent
        • Tags
        • Popular
        • Users
        • Groups